Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
Background High-throughput genomic profiling of tumour specimens facilitates the identification of individual actionable mutations which could be used for individualised targeted therapy. This approach is becoming increasingly more common in the clinic; however, the interpretation of results from mo...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-07-01
|
| Series: | ESMO Open |
| Online Access: | https://esmoopen.bmj.com/content/4/4/e000538.full |